Yih-Yun Sun
Overview
Explore the profile of Yih-Yun Sun including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
21
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Li P, Sun Y, Juan H, Chen C, Tsai H, Huang J
Brief Bioinform
. 2025 Feb;
26(1).
PMID: 39998433
With the exponential growth of biomedical literature, leveraging Large Language Models (LLMs) for automated medical knowledge understanding has become increasingly critical for advancing precision medicine. However, current approaches face significant...
2.
Liu Y, Sun Y, Simonelli A, Farina R, Trombelli L, Wang C, et al.
Clin Implant Dent Relat Res
. 2025 Feb;
27(1):e70010.
PMID: 39948703
Objective: In this update of a previous systematic review, we compared the effects of surgical and non-surgical treatments for peri-implantitis through the component network meta-analysis (CNMA) with probing depth (PD)...
3.
Sun Y, Hsieh C, Wen J, Tseng T, Huang J, Oyang Y, et al.
Biomed Pharmacother
. 2024 Jul;
177:117070.
PMID: 38964180
Predicting drug responses based on individual transcriptomic profiles holds promise for refining prognosis and advancing precision medicine. Although many studies have endeavored to predict the responses of known drugs to...
4.
Lin T, Sun Y, Wang C, Cheng W, Lu I, Lin C, et al.
Bioinform Adv
. 2023 Jan;
2(1):vbac080.
PMID: 36699402
Motivation: Antiviral peptides (AVPs) from various sources suggest the possibility of developing peptide drugs for treating viral diseases. Because of the increasing number of identified AVPs and the advances in...
5.
Sun Y, Lin T, Cheng W, Lu I, Lin C, Chen S
Pharmaceuticals (Basel)
. 2022 Apr;
15(4).
PMID: 35455418
Anticancer peptides (ACPs) are selective and toxic to cancer cells as new anticancer drugs. Identifying new ACPs is time-consuming and expensive to evaluate all candidates' anticancer abilities. To reduce the...